Share Email Print
cover

Proceedings Paper

Follow-up segmentation of lung tumors in PET and CT data
Author(s): Roland Opfer; Sven Kabus; Torben Schneider; Ingwer C. Carlsen; Steffen Renisch; Jörg Sabczynski
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Early response assessment of cancer therapy is a crucial component towards a more effective and patient individualized cancer therapy. Integrated PET/CT systems provide the opportunity to combine morphologic with functional information. We have developed algorithms which allow the user to track both tumor volume and standardized uptake value (SUV) measurements during the therapy from series of CT and PET images, respectively. To prepare for tumor volume estimation we have developed a new technique for a fast, flexible, and intuitive 3D definition of meshes. This initial surface is then automatically adapted by means of a model-based segmentation algorithm and propagated to each follow-up scan. If necessary, manual corrections can be added by the user. To determine SUV measurements a prioritized region growing algorithm is employed. For an improved workflow all algorithms are embedded in a PET/CT therapy monitoring software suite giving the clinician a unified and immediate access to all data sets. Whenever the user clicks on a tumor in a base-line scan, the courses of segmented tumor volumes and SUV measurements are automatically identified and displayed to the user as a graph plot. According to each course, the therapy progress can be classified as complete or partial response or as progressive or stable disease. We have tested our methods with series of PET/CT data from 9 lung cancer patients acquired at Princess Margaret Hospital in Toronto. Each patient underwent three PET/CT scans during a radiation therapy. Our results indicate that a combination of mean metabolic activity in the tumor with the PET-based tumor volume can lead to an earlier response detection than a purely volume based (CT diameter) or purely functional based (e.g. SUV max or SUV mean) response measures. The new software seems applicable for easy, faster, and reproducible quantification to routinely monitor tumor therapy.

Paper Details

Date Published: 3 March 2009
PDF: 9 pages
Proc. SPIE 7260, Medical Imaging 2009: Computer-Aided Diagnosis, 72600X (3 March 2009); doi: 10.1117/12.811599
Show Author Affiliations
Roland Opfer, Philips Research (Germany)
Sven Kabus, Philips Research (Germany)
Torben Schneider, Philips Research (Germany)
Ingwer C. Carlsen, Philips Research (Germany)
Steffen Renisch, Philips Research (Germany)
Jörg Sabczynski, Philips Research (Germany)


Published in SPIE Proceedings Vol. 7260:
Medical Imaging 2009: Computer-Aided Diagnosis
Nico Karssemeijer; Maryellen L. Giger, Editor(s)

© SPIE. Terms of Use
Back to Top